Thanks, hump4, for the link[more to chat about at lunch ~2 weeks]:
"Teachers Advisors LLC bought a new stake in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor bought 126,696 shares of the biopharmaceutical company’s stock, valued at approximately $350,000. Teachers Advisors LLC owned approximately 0.15% of Catalyst Pharmaceuticals as of its most recent filing with the SEC.
Several other large investors have also made changes to their positions in CPRX. Bank of New York Mellon Corp lifted its stake in Catalyst Pharmaceuticals by 3.6% during the first quarter. Bank of New York Mellon Corp now owns 69,176 shares of the biopharmaceutical company’s stock valued at $135,000 after purchasing an additional 2,404 shares during the last quarter. JPMorgan Chase & Co. acquired a new stake in Catalyst Pharmaceuticals during the first quarter valued at approximately $155,000. Vanguard Group Inc. lifted its stake in Catalyst Pharmaceuticals by 0.5% during the first quarter. Vanguard Group Inc. now owns 3,007,935 shares of the biopharmaceutical company’s stock valued at $5,865,000 after purchasing an additional 15,600 shares during the last quarter. Geode Capital Management LLC lifted its stake in Catalyst Pharmaceuticals by 0.3% during the first quarter. Geode Capital Management LLC now owns 462,677 shares of the biopharmaceutical company’s stock valued at $902,000 after purchasing an additional 1,446 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in shares of Catalyst Pharmaceuticals in the 1st quarter valued at approximately $746,000. 41.31% of the stock is owned by institutional investors and hedge funds."
